Mission
To democratize mental
healthand well being
Mission:
To democratize mental
healthand well being

About Mind Pharma

Mind Pharmaceuticals is a Clinical Asset Stage Company based in New Haven, CT is targeting unmet needs in the CNS space with an initial focus on Treatment Resistant Depression and Headache Disorders.
MIND is advancing scalable psychedelic therapies for treatment-resistant CNS disorders, delivering more durable efficacy with fewer side effects while reducing the operational complexity of existing treatment models

Team

Krishna P. Ravindranathan, PhD

Krishna P. Ravindranathan, PhD

Founder, CEO
  • Founder/former CEO Genome Shield Diagnostics.
  • Postdoc Yale Pharmacology and Chemistry, with Yossi Schlessinger and William Jorgensen.
  • Drug discovery, translational drug development.
Christopher Pittenger, MD, PhD

Christopher Pittenger, MD, PhD

Co-Founder, Chair – Scientific Advisory Board, Interim CMO
  • Professor & Deputy Chair, Psychiatry, Yale University.
  • Director, Yale Program for Psychedelic Science.
  • Director, Clinical Neuroscience Research Unit.
Prakash K Mandgi

Prakash K Mandgi, MBA

Co-Founder, CFO

  • Director Investment Banking (former), Midtown Partners.
  • Participated in transactions totaling $250M+.
  • MBA University of Chicago, MS Biomedical Engineering CWRU.
John Krystal, MD

John Krystal, MD

Member – Scientific Advisory Board

  • Professor & Chair, Dept. of Psychiatry, Yale.
  • Physician in Chief of Psychiatry, Yale New Haven Hospital.
  • Discovered antidepressant effect of Ketamine.
Ray Sanchez, MD

Ray Sanchez, MD

Member – Scientific Advisory Board

  • CMO (former) Cerevel, acquired by AbbVie.
  • Senior Vice President, Global Clinical Development (former), Otsuka.
  • Abilify, Abilify (Maintena), Rexulti, Abilify MyCite.
Fred Barrett, PhD

Fred Barrett, PhD

Member – Scientific Advisory Board

  • Professor & Director, Johns Hopkins School of Medicine Center for Psychedelic and Consciousness Research.
  • Dept. Psychiatry and Behavioral Sciences, Neuroscience, Behavioral Pharmacology Unit.